Related Experiment Videos
The effect of pharmacological agents on ejaculation.
The Journal of Urology
|October 1, 1975
Summary
Pharmacological agents causing sympatholytic activity can lead to ejaculatory failure by preventing seminal vesicle and ductus deferens contractions. This suggests alpha-adrenergic blockers may offer a reversible male contraceptive option.
Area of Science:
- Reproductive medicine
- Pharmacology
- Urology
Background:
- Infertility can arise from various causes, including medication side effects.
- Ejaculatory dysfunction is a complex condition affecting male fertility.
- Retrograde ejaculation was previously considered a primary cause of infertility in patients on certain medications.
Purpose of the Study:
- To investigate the cause of infertility in a patient using sympatholytic pharmacological agents.
- To determine the mechanism of ejaculatory failure induced by alpha-adrenergic blockers.
- To explore the potential of alpha-adrenergic blocking agents as reversible male contraceptives.
Main Methods:
- Clinical case study of a patient experiencing infertility.
- Analysis of ejaculatory function and seminal vesicle, ampulla, and ductus deferens contractions.
- Pharmacological assessment of sympatholytic agents and their effects on adrenergic pathways.
Main Results:
- Infertility was attributed to ejaculatory failure due to absent contractions of the seminal vesicle, ampulla, and ductus deferens.
- Retrograde ejaculation was ruled out as the primary cause.
- The findings implicate pharmacological agents with alpha-adrenergic blockage in temporary ejaculatory interference.
Conclusions:
- Pharmacological agents with sympatholytic activity, specifically those causing alpha-adrenergic blockage, can induce ejaculatory failure.
- This mechanism differs from the previously assumed retrograde ejaculation.
- Alpha-adrenergic blockers show potential for development as reversible male contraceptives.